Paid Clinical Trials and Focus Groups by Category |
|
|
|
Conditions: Peanut Hypersensitivity; Food Hypersensitivity; Immediate Hypersensitivity
Interventions: Drug: Peanut powder; Drug: Peanut extract; Drug: Placebo extract; Drug: Placebo powder
Sponsor: Johns Hopkins University
Recruiting - verified March 2010
Condition: Asthma
Interventions: Drug: BI 671800; Drug: BI 671800; Drug: BI 671800; Drug: Placebo
Sponsor: Boehringer Ingelheim Pharmaceuticals
Not yet recruiting - verified March 2010
Conditions: HIV; Cardiovascular Disease
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Bronchial Asthma
Intervention: Other: medical documentation and telephone interview
Sponsor: Medical Universtity of Lodz
Recruiting - verified March 2010
Condition: Influenza A Virus, H5N1 Subtype
Interventions: Biological: VRC-AVIDNA036-00-VP; Biological: Monovalent Influenza Subunit Virion (Inactive H5N1) Vaccine
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Conditions: Allergic Rhinoconjunctivitis; Chronic Urticaria
Intervention: Drug: Bilastine
Sponsor: Faes Farma, S.A.
Recruiting - verified March 2010
Condition: Asthma
Interventions: Drug: Fluticasone Furoate/GW642444; Drug: Fluticasone furoate
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Asthma
Interventions: Other: 1; Other: 2
Sponsor: AstraZeneca
Not yet recruiting - verified March 2010
Condition: Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
Interventions: Biological: Rituximab; Other: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified March 2010
Condition: Influenza
Intervention: Biological: Inactivated Influenza A/H5N1/Indonesia/05/05 (clade 2)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified February 2010
Condition: Asthma
Intervention:
Sponsor: King Saud University
Recruiting - verified March 2010
Condition: Dengue Virus
Interventions: Biological: Investigational Vaccine for DEN1; Other: Placebo injection
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2010
Conditions: HIV; Infant, Newborn; Anemia; Neutropenia
Intervention: Drug: cotrimoxazole
Sponsors: Harvard School of Public Health; National Institute of Allergy and Infectious Diseases (NIAID); John E. Fogarty International Center (FIC); Harvard Initiative for Global Health; American Society of Tropical Medicine and Hygiene
Recruiting - verified March 2010
Condition: Sickle Cell Disease
Intervention: Drug: Lexiscan
Sponsors: Dana-Farber Cancer Institute; Brigham and Women's Hospital; Children's Hospital Boston; Washington University School of Medicine; LaJolla Institute for Allergy and Immunology; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified March 2010
Conditions: Infection; Osteoarthritis of the Knee
Interventions: Device: Simplex™ P with Tobramycin; Device: Simplex™ P
Sponsor: University of Western Ontario, Canada
Not yet recruiting - verified March 2010
Condition: Food Allergy
Intervention:
Sponsor: University of Erlangen-Nürnberg Medical School
Not yet recruiting - verified February 2010
Condition: Asthma
Interventions: Drug: Indacaterol dose; Drug: Placebo; Drug: Salmeterol
Sponsor: Novartis Pharmaceuticals
Recruiting - verified March 2010
Condition: Acute Asthma
Interventions: Behavioral: Opinion Leader; Behavioral: Usual care
Sponsor: University of Alberta
Not yet recruiting - verified February 2010
Condition: Mild to Moderate Atopic Dermatitis
Interventions: Device: Atopiclair; Device: EHK02-01
Sponsor: Bitop AG
Recruiting - verified March 2010
Condition: Asthma
Interventions: Drug: propranolol; Drug: placebo
Sponsors: University of Dundee; Chief Scientist Office of the Scottish Government
Not yet recruiting - verified February 2010
Conditions: Ovarian Cancer; Bowel Obstruction
Interventions: Drug: Cisplatin; Drug: Paclitaxel
Sponsor: University Health Network, Toronto
Recruiting - verified February 2010
Condition: Chronic Urticaria
Interventions: Drug: Placebo; Drug: Hydroxychloroquine
Sponsor: Vanderbilt University
Not yet recruiting - verified February 2010
Condition: Persistent Asthma
Intervention:
Sponsor: AstraZeneca
Recruiting - verified March 2010
Conditions: Psoriasis; Atopic Dermatitis
Interventions: Behavioral: education on skin disease conditions; Behavioral: Stress-reduction techniques; Behavioral: Lifestyle factors and psycho-education; Other: no educational program
Sponsor: University Hospital, Ghent
Recruiting - verified February 2010
Condition: Asthma
Interventions: Drug: Meptin® Swinghaler; Drug: Ventolin® MDI
Sponsor: Taiwan Otsuka Pharm. Co., Ltd
Recruiting - verified February 2010
Condition: Asthma
Intervention:
Sponsors: University of California, San Francisco; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Asthma
Intervention: Drug: paracetamol
Sponsor: Tel-Aviv Sourasky Medical Center
Not yet recruiting - verified February 2010
Condition: Atopic Dermatitis
Interventions: Other: Standard of care eczema treatment; Device: Accu-patch pellets
Sponsor: Northwestern University
Recruiting - verified February 2010
Condition: Systemic Lupus Erythematosus
Intervention:
Sponsors: North Shore Long Island Jewish Health System; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Pancreatitis
Interventions: Drug: Precedex; Drug: sodium chlorid 0,9%
Sponsor: Helsinki University Central Hospital
Recruiting - verified August 2009
Condition: Dengue
Interventions: Biological: TetraVax-DV Vaccine-Admixture 1; Biological: TetraVax-DV Vaccine-Admixture 2; Biological: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Center for Immunization Research (CIR), Johns Hopkins Bloomberg School of Public Health
Not yet recruiting - verified February 2010
Condition: Dengue Virus
Interventions: Biological: Investigational Vaccine for Dengue Virus Subtype 2; Other: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Conditions: Cryptococcal Meningitis; HIV Infections; AIDS
Interventions: Other: Early HIV Therapy Initiation; Other: Standard HIV Therapy Initiation
Sponsors: University of Minnesota - Clinical and Translational Science Institute; Makerere University; Mbarara University of Science and Technology; National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified February 2010
Condition: Asthma
Intervention: Other: Quest for the Code
Sponsors: Winthrop University Hospital; Asthma Coalition of Long Island
Recruiting - verified February 2010
Conditions: Tuberculosis; Tuberculosis, Multidrug-Resistant; Extensively Drug Resistant Tuberculosis
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2010
Conditions: C. Trachomatis; Gonococcal Infections
Interventions: Drug: Azithromycin; Drug: Placebo; Drug: Cefixime
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified February 2010
Condition: Chronic Plaque-type Psoriasis
Interventions: Drug: AIN457; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - verified February 2010
Condition: Asthma
Intervention: Other: Electronic Asthma Action Plan System
Sponsor: St. Michael's Hospital, Toronto
Not yet recruiting - verified February 2010
Condition: Perennial Allergic Rhinitis
Intervention: Drug: ciclesonide HFA 160 μg
Sponsor: Sepracor, Inc.
Recruiting - verified February 2010
Conditions: Medication Reconciliation; Emergency Department
Intervention: Other: Medication reconciliation completed by a RN, CPhT, or RPh
Sponsors: Wesley Medical Center; Cardinal Health Foundation
Recruiting - verified January 2010
Condition: HIV Infections
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Gilead Sciences
Not yet recruiting - verified January 2009
Condition: Hereditary Angioedema
Intervention:
Sponsor: Dyax Corp.
Recruiting - verified February 2010
Conditions: Asthma; Cough Variant Asthma
Interventions: Drug: high-dose methacholine challenge test; Other: mannitol challenge test
Sponsor: Queen's University
Recruiting - verified March 2010
Conditions: Chronic Granulomatous Disease (CGD); Atherosclerosis; Immune Deficiencies; Inflammatory Bowel Disease
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2009
Condition: Influenza
Intervention: Drug: Peramivir
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified January 2010
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: JNJ38224342/placebo; Drug: JNJ38224342/placebo; Drug: JNJ38224342; Drug: JNJ38224342/placebo
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Not yet recruiting - verified February 2010
Condition: HIV Infections
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Asthma
Interventions: Drug: Albuterol DPI; Drug: Albuterol MDI; Drug: Placebo HFA MDI and Placebo DPI
Sponsor: Teva Global Respiratory Research LLC
Recruiting - verified February 2010
Condition: Asthma
Interventions: Dietary Supplement: Fish Oil; Dietary Supplement: Ascorbic Acid; Dietary Supplement: Fish Oil Placebo; Dietary Supplement: Ascorbic Acid Placebo
Sponsor: Indiana University
Recruiting - verified March 2010
Condition: Neuroblastoma
Interventions: Biological: aldesleukin; Biological: monoclonal antibody Ch14.18; Biological: sargramostim; Drug: isotretinoin; Other: laboratory biomarker analysis
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified March 2010
Condition: HIV Infections
Interventions: Drug: Emtricitabine (FTC); Drug: Tenofovir disoproxil fumarate (TDF); Drug: Efavirenz (EFV)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified December 2009
Conditions: Tick-Borne Encephalitis; Encephalitis, Tick-Borne; Tick-Borne Disease; Glycoprotein E, Flavivirus; NSI Protein, Flavivirus
Intervention: Biological: FSME-IMMUN 0.5ml Baxter
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified September 2009
Condition: Skin Cancer
Interventions: Dietary Supplement: Omega-3 PUFA; Dietary Supplement: Gelatine
Sponsor: University of Manchester
Recruiting - verified March 2010
Condition: Human Papillomavirus
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified March 2010
Condition: HIV Infections
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified December 2009
Condition: Asthma
Interventions: Drug: SCH 32088 mometasone furoate (MF) metered-dose inhaler; Drug: Placebo metered-dose inhaler BID
Sponsor: Schering-Plough
Not yet recruiting - verified March 2010
Condition: Plasmodium Falciparum Malaria
Interventions: Biological: EBA-175 RII-NG Malaria Vaccine; Drug: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified October 2009
Condition: Sensitivity in Esophagus
Interventions: Drug: AZD1386; Drug: Placebo to AZD1386
Sponsor: AstraZeneca
Recruiting - verified March 2010
Condition: Asthma
Interventions: Drug: AMG 853; Drug: AMG 853; Drug: AMG 853; Drug: AMG 853; Drug: Placebo
Sponsor: Amgen
Recruiting - verified March 2010
Condition: Malaria
Interventions: Biological: Ad35.CS.01; Drug: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified October 2009
Condition: Asthma
Interventions: Drug: Olodaterol (BI 1744); Drug: Olodaterol (BI 1744); Drug: Olodaterol (BI 1744) low; Drug: Olodaterol (BI 1744) high; Drug: Formoterol 12 mcg; Drug: Placebo
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Veramyst /Artificial tears; Drug: Veramyst / Artificial tears lubricant eye drops; Drug: Veramyst nasal spray and Olopatadine eye drops; Other: Veramyst placebo and Olopatadine0.2% eye drops
Sponsors: University of Chicago; GlaxoSmithKline
Recruiting - verified November 2009
Conditions: Herpesvirus; Adenovirus; Cytomegalovirus; Human Papillomavirus; Human Polyomavirus; Influenza Virus; Rhinovirus; Coronavirus; Respiratory Syncytial Virus
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified October 2009
Condition: Asthma
Interventions: Drug: Fluticasone Furoate/GW642444; Drug: Fluticasone propionate
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Conditions: Rhinitis, Allergic, Seasonal; Asthma
Interventions: Drug: BI 67100 ED 25 mg; Drug: BI 671800 ED placebo; Drug: montelukast placebo tablet; Drug: montelukast placebo tablet; Drug: fluticasone propionate placebo nasal spray; Drug: fluticasone propionate placebo nasal spray; Drug: fluticasone propionate placebo nasal spray; Drug: BI 671800 ED 100 mg; Drug: BI 671800 ED placebo; Drug: BI 671800 ED placebo; Drug: BI 671800 ED placebo; Drug: BI 671800 ED 100 mg; Drug: 671800 ED placebo; Drug: montelukast placebo tablet; Drug: montelukast placebo tablet; Drug: montelukast placebo tablet; Drug: montelukast 10 mg tablet; Drug: fluticasone propionate placebo nasal spray; Drug: fluticasone propionate nasal spray placebo; Drug: Fluticasonepropionate nasal spray 200 mcg
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Hereditary Angioedema
Intervention: Drug: Icatibant
Sponsor: Jerini AG
Recruiting - verified October 2009
Condition: Asthma
Intervention: Biological: Mepolizumab (treatment) - Severe asthma
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Influenza, Human
Intervention: Biological: VRC-FLUDNA056-00VP
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified October 2009
Condition: Hypersensitivity
Interventions: Drug: Sugammadex 4 mg/kg; Drug: Sugammadex 16 mg/kg; Drug: Placebo
Sponsor: Schering-Plough
Recruiting - verified March 2010
Condition: Influenza
Intervention: Biological: Inactivated H1N1 Vaccine
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2009
Condition: Influenza
Intervention: Biological: Inactivated Influenza H1N1 vaccine
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2010
Conditions: Epithelial Ovarian Cancer; Primary Peritoneal Cancer; Fallopian Tube Cancer
Interventions: Drug: Paclical®; Drug: Taxol®
Sponsors: Oasmia Pharmaceutical AB; Orion Corporation, Orion Pharma
Recruiting - verified February 2010
Condition: HIV Infections
Intervention: Behavioral: Modified client adherence profiling and intervention tailoring (CAP-IT)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified October 2009
Conditions: HIV Infections; Hepatitis C Virus
Interventions: Drug: Nitazoxanide (NTZ); Drug: Peginterferon alfa-2a (PEG-INF); Drug: Ribavirin (RBV)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified October 2009
Condition: Rhinosinusitis
Intervention: Device: FinESS Sinus Treatment
Sponsor: Entellus Medical, Inc.
Recruiting - verified March 2010
Condition: HIV Infections
Interventions: Behavioral: Enhanced nursing telephone support; Behavioral: Standard care
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified October 2009
Conditions: Asthma; Pulmonary Disease, Chronic Obstructive
Intervention: Other: Empty inhalers
Sponsor: Orion Corporation, Orion Pharma
Recruiting - verified February 2010
Condition: Allergic Rhinitis
Interventions: Drug: Ibuprofen; Drug: Fluticasone propionate; Drug: Placebo
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: C. Trachomatis
Interventions: Drug: Azithromycin; Drug: Doxycycline
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2009
Condition: HIV Infections
Interventions: Drug: Raltegravir (RAL); Drug: Atazanavir (ATV); Drug: Ritonavir (RTV); Drug: Tenofovir (TDF); Drug: Etravirine (ETV); Drug: Darunavir (DRV); Drug: Maraviroc (MVC); Drug: Lopinavir/ritonavir (LPV/r)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified September 2009
Condition: Atopic Dermatitis
Interventions: Device: Sinecort cream; Drug: Hydrocortison cream; Other: untreated skin
Sponsor: Bayer
Recruiting - verified March 2010
Condition: Staphylococcus Enterotoxin B
Intervention: Biological: STEBVax
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified February 2010
Condition: Asthma
Interventions: Biological: MEDI-528; Biological: MEDI-528; Biological: MEDI-528; Other: Placebo
Sponsor: MedImmune LLC
Recruiting - verified March 2010
Condition: Alcoholism
Interventions: Drug: Ethanol; Drug: Placebo; Drug: Diphenhydramine; Drug: Caffeine
Sponsors: University of Chicago; National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified March 2010
Condition: HIV Infections
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified August 2009
Conditions: Functional Dyspepsia; Small Intestinal Bacterial Overgrowth; Chronic Abdominal Discomfort
Interventions: Drug: Rifaximin; Procedure: Lactulose Breath Test; Drug: Placebo
Sponsor: National Institutes of Health (NIH)
Recruiting - verified February 2010
Condition: HIV Infections
Intervention: Drug: Highly active antiretroviral therapy (HAART)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2010
Condition: Severe Asthma
Intervention:
Sponsor: University of Alberta
Not yet recruiting - verified March 2010
Conditions: Neuropathic Pain; Mechanical Hypersensitivity
Interventions: Drug: AZD2066; Drug: Placebo
Sponsors: AstraZeneca; Quintiles
Recruiting - verified March 2010
Condition: Asthma
Intervention: Drug: JNJ39758979
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting - verified February 2010
Condition: Asthma
Interventions: Drug: QMF149 Twisthaler®; Drug: Mometasone Twisthaler®
Sponsor: Novartis Pharmaceuticals
Recruiting - verified March 2010
Conditions: HIV; Asthma
Interventions: Drug: Darunavir; Drug: Ritonavir; Drug: Beclomethasone Dipropionate HFA
Sponsor: National Institutes of Health Clinical Center (CC)
Recruiting - verified July 2009
Conditions: HIV; HIV Infections
Interventions: Drug: emtricitabine/tenofovir + lopinavir/ritonavir (WHO recommended second line); Drug: abacavir + didanosine + lopinavir/ritonavir (WHO recommended second line); Drug: emtricitabine/tenofovir + darunavir + ritonavir (Second line strategy under evaluation)
Sponsors: French National Agency for Research on AIDS and Viral Hepatitis; Gilead Sciences; Janssen Pharmaceutica N.V., Belgium
Recruiting - verified February 2010
Condition: Gonococcal Infections
Interventions: Drug: Azithromycin; Drug: Gentamicin; Drug: Gemifloxacin
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified February 2010
Conditions: Hereditary Angioedema; C1 Esterase Inhibitor Deficiency
Intervention: Biological: C1 inhibitor (human)
Sponsor: ViroPharma
Recruiting - verified August 2009
Condition: Hereditary Angioedema
Interventions: Drug: Icatibant; Drug: Placebo
Sponsors: Jerini AG; Shire Human Genetic Therapies, Inc.
Recruiting - verified November 2009
Condition: Metastatic Breast Cancer
Interventions: Drug: Everolimus; Drug: Bevacizumab; Drug: Paclitaxel; Drug: Placebo; Drug: Bevacizumab; Drug: Paclitaxel
Sponsors: Sarah Cannon Research Institute; Novartis
Recruiting - verified January 2010
Condition: Variola Major (Smallpox)
Interventions: Biological: IMVAMUNE® (liquid, intradermal); Biological: IMVAMUNE® (lyophilized); Biological: IMVAMUNE® (liquid, subcutaneous)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Arformoterol; Drug: Placebo
Sponsor: Sepracor, Inc.
Recruiting - verified February 2010
Condition: Influenza
Interventions: Biological: A/Anhui/05; Biological: MF-59; Drug: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified December 2009
Condition: Haemophilus Influenzae (NTHI)
Intervention: Biological: NTHi Strain 2019
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified December 2009
Conditions: Anaphylaxis; Hypotension; Bronchospasm; Angioedema
Interventions: Drug: Epinephrine; Procedure: Bone Marrow Apsiration; Drug: Omalizumab (Xolair)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Conditions: Lymphohistiocytosis, Hemophagocytic; Common Variable Immunodeficiency; Severe Combined Immunodeficiency
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Systemic Juvenile Idiopathic Arthritis
Intervention: Drug: Canakinumab
Sponsors: Novartis Pharmaceuticals; PRINTO / PRCSG
Recruiting - verified August 2009
Conditions: Autoinflammatory Syndromes; Physical Urticaria
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Malaria
Intervention: Drug: BSAM2/Alhydrogel + CPG 7909
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2009
Condition: Allergic Airway Disease
Intervention: Drug: Broccoli sprout extract
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2009
Condition: Systemic Juvenile Idiopathic Arthritis
Interventions: Drug: Canakinumab; Drug: Placebo
Sponsors: Novartis Pharmaceuticals; PRINTO / PRCSG
Recruiting - verified August 2009
Condition: Systemic Juvenile Idiopathic Arthritis With Active Flare
Interventions: Drug: Canakinumab; Drug: Placebo
Sponsors: Novartis Pharmaceuticals; PRINTO / PRCSG
Recruiting - verified December 2009
Conditions: Cryptococcal Meningitis; HIV Infections
Interventions: Drug: Fluconazole; Drug: Amphotericin B
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Conditions: Idiopathic Pulmonary Fibrosis; Pulmonary Hypertension
Intervention: Drug: Ambrisentan or placebo
Sponsor: Gilead Sciences
Recruiting - verified March 2010
Condition: Asthma
Interventions: Drug: PF-03526299; Drug: Placebo; Drug: Fluticasone propionate
Sponsor: Pfizer
Recruiting - verified March 2010
Conditions: HIV Infections; Tuberculosis
Intervention: Other: Standardized diagnostic evaluation
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Adult AIDS Clinical Trials Group; National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified June 2009
Conditions: HIV Infections; Peripheral Neuropathy
Interventions: Drug: Duloxetine; Drug: Duloxetine placebo; Drug: Methadone; Drug: Methadone placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2009
Condition: Asthma
Intervention: Drug: budesonide
Sponsor: Kuopio University Hospital
Recruiting - verified March 2010
Conditions: Herpes Zoster; HIV Infections
Interventions: Biological: Zoster Vaccine Live; Biological: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Adult AIDS Clinical Trials Group; Merck
Recruiting - verified May 2009
Conditions: HIV Infections; Treatment Naive
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2010
Conditions: Chronic Sinusitis; Chronic Rhinosinusitis; Nasal Polyps
Intervention: Drug: Prednisone
Sponsor: Northwestern University
Recruiting - verified February 2010
Conditions: Allergy; Rhinoconjunctivitis
Intervention: Biological: Immunotherapy with modified extract of Olea europaea pollen
Sponsor: Laboratorios Leti, S.L.
Recruiting - verified March 2010
Condition: Intestinal Microbiome
Intervention: Drug: Ciprofloxacin hydrochloride
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified March 2009
Condition: HIV Infections
Interventions: Biological: Vaccine; Biological: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2009
Condition: Atopic Dermatitis
Interventions: Biological: ROUVAX; Biological: placebo
Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; Ministry of Health, France
Recruiting - verified March 2010
Condition: Tuberculosis
Interventions: Drug: RIF; Drug: INH; Drug: PZA; Drug: KM; Drug: MXF
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); NIAID, Korean Ctr for Dx Control and Prevention, Inter Tuberculosis Research Ctr, Novartis Inst for Tropical Medicine, Asian Medical Ctr, Korean Center
Not yet recruiting - verified September 2009
Condition: Asthma
Interventions: Drug: Levalbuterol; Drug: Levalbuterol UDV TID; Drug: Placebo
Sponsor: Sepracor, Inc.
Recruiting - verified February 2010
Condition: HIV Infections
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate; Drug: Raltegravir; Drug: Darunavir; Drug: Ritonavir
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Bristol-Myers Squibb; Gilead Sciences; Merck; Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA
Recruiting - verified June 2009
Conditions: HIV Infections; Tuberculosis; Coinfection
Interventions: Drug: EFV and two NRTIs; Drug: Rifampin-containing anti-tuberculosis therapy
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified December 2008
Condition: Breast Cancer
Interventions: Biological: aldesleukin; Biological: allogeneic large multivalent immunogen breast cancer vaccine; Other: flow cytometry; Other: immunoenzyme technique; Other: laboratory biomarker analysis
Sponsors: Masonic Cancer Center, University of Minnesota; National Cancer Institute (NCI)
Recruiting - verified March 2010
Conditions: Rhinitis; Allergic Conjunctivitis
Interventions: Biological: 6 Amb a 1-U; Biological: 12 Amb a 1-U; Biological: Placebo
Sponsor: Schering-Plough
Recruiting - verified March 2010
Conditions: Wiskott-Aldrich Syndrome (WAS); X-linked Thrombocytopenia
Intervention: Drug: Interleukin-2
Sponsors: Children's Hospital of Philadelphia; Novartis
Recruiting - verified March 2010
Conditions: Lupus Nephritis; Lupus Erythematosus, Systemic
Interventions: Drug: Abatacept; Drug: cyclophosphamide; Drug: azathioprine; Drug: prednisone; Drug: abatacept placebo; Drug: azathioprine placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Immune Tolerance Network
Recruiting - verified February 2010
Condition: Asthma
Interventions: Drug: tiotropium 5mcg/day; Drug: tiotropium 5mcg/day
Sponsors: Boehringer Ingelheim Pharmaceuticals; Pfizer
Recruiting - verified March 2010
Condition: Asthma
Interventions: Drug: tiotropium 5mcg/day; Drug: tiotropium 5mcg/day
Sponsors: Boehringer Ingelheim Pharmaceuticals; Pfizer
Recruiting - verified March 2010
Conditions: Rhinitis; Allergic Conjunctivitis
Interventions: Biological: 1.5 Amb a 1-U; Biological: 6 Amb a 1-U; Biological: 12 Amb a 1-U; Biological: Placebo
Sponsor: Schering-Plough
Recruiting - verified March 2010
Condition: Allergic Conjunctivitis
Interventions: Drug: Ketotifen/naphazoline; Drug: Ketotifen/naphazoline and Vehicle; Drug: Ketotifen/naphazoline and Naphazoline; Drug: Ketotifen/naphazoline and Ketotifen; Drug: Ketotifen and Ketotifen/naphazoline; Drug: Ketotifen and Vehicle; Drug: Ketotifen and Naphazoline; Drug: Ketotifen; Drug: Naphazoline and Ketotifen/naphazoline; Drug: Naphazoline and Vehicle; Drug: Naphazoline; Drug: Naphazoline and Ketotifen; Drug: Vehicle and Ketotifen/naphazoline; Drug: Vehicle; Drug: Vehicle and Naphazoline; Drug: Vehicle and Ketotifen
Sponsor: Bausch & Lomb, Inc.
Recruiting - verified February 2010
Condition: HIV Infections
Intervention: Drug: Vicriviroc
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2009
Conditions: Rhinitis, Allergic, Seasonal; Rhinitis, Allergic, Perennial; Urticaria
Intervention: Drug: desloratadine
Sponsor: Schering-Plough
Recruiting - verified March 2010
Condition: Plasmodium Falciparum Malaria
Intervention: Other: NF54 P. falciparum isolate
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified March 2010
Condition: Papillomavirus Infections
Intervention:
Sponsors: University of Washington; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Methicillin-Resistant S.Aureus
Interventions: Drug: Cephalexin; Drug: Trimethoprim-sulfamethoxazole (TS); Drug: Clindamycin; Drug: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified December 2009
Condition: Methicillin-Resistant S.Aureus
Interventions: Drug: Clindamycin; Drug: Trimethoprim-sulfamethoxazole (TS); Drug: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2010
Condition: Atopic Dermatitis
Intervention: Biological: YFV-17D
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Conditions: Bronchial Asthma; Signs and Symptoms, Respiratory; Allergy
Intervention: Device: Spirometry (Pony spirometer)
Sponsor: Carmel Medical Center
Recruiting - verified March 2010
Conditions: Diphtheria; Pertussis; Tetanus
Interventions: Drug: Placebo; Biological: Tdap
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified March 2010
Condition: HIV Infections
Interventions: Drug: Highly Active Antiretroviral Therapy (HAART); Other: No treatment
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2010
Condition: HIV Infections
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2009
Conditions: Dermatitis, Atopic; Eczema, Atopic; Skin Diseases, Eczematous
Interventions: Drug: Cream (betamethasone diproprionate, clotrimazole, and gentamicin sulfate); Drug: Cream (betamethasone diproprionate and gentamicin); Drug: Cream (betamethasone diproprionate)
Sponsor: Schering-Plough
Recruiting - verified March 2010
Condition: Bronchiectasis
Interventions: Drug: Inhaled mannitol; Drug: matched control
Sponsor: Pharmaxis
Recruiting - verified March 2010
Condition: Malaria
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Bacterial Vaginosis
Interventions: Drug: Metronidazole; Other: No Intervention
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2009
Condition: Escherichia Coli Infections
Interventions: Drug: Ciprofloxacin 500 mg; Biological: Peru-15-pCTB; Drug: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Primary Immunodeficiency Disease
Intervention: Biological: Flebogamma 5% DIF
Sponsor: Grifols Biologicals Inc.
Recruiting - verified March 2010
Condition: Asthma
Intervention:
Sponsors: University of Kansas; Kansas University Endowment Association
Recruiting - verified March 2010
Condition: HIV Infections
Intervention: Biological: Ad26.ENVA.01 HIV-1 vaccine
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2008
Conditions: HIV Infections; Sexually Transmitted Diseases
Intervention: Biological: Quadrivalent human papillomavirus vaccine
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified June 2009
Conditions: Asthma; Obesity
Intervention:
Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting - verified December 2007
Conditions: Cancer; Leukemia; Myelodysplastic Syndrome; Non-Hodgkin's Lymphoma
Interventions: Drug: Fludarabine, Cyclophosphamide; Procedure: Transplantation
Sponsor: Memorial Sloan-Kettering Cancer Center
Recruiting - verified February 2010
Condition: Variola Major (Smallpox)
Interventions: Biological: MVA-BN; Drug: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified October 2009
Condition: Inflammatory Disorder
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2009
Conditions: Polymorphic Light Eruption; Psoriasis; Atopic Eczema
Intervention:
Sponsor: Medical University of Graz
Recruiting - verified March 2010
Condition: Atopic Dermatitis
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Atopic Dermatitis and Vaccinia Network
Recruiting - verified February 2010
Condition: Leukemia
Intervention: Drug: asparaginase-Erwinia
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified March 2010
Condition: HIV Infections
Interventions: Drug: Enfuvirtide; Drug: Raltegravir; Drug: Darunavir; Drug: Tipranavir; Drug: Etravirine; Drug: Maraviroc
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Adult AIDS Clinical Trials Group
Recruiting - verified April 2009
Condition: Coronavirus (SARS-CoV)
Interventions: Drug: Aluminum hydroxide; Biological: SARS-CoV; Drug: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: IL-2; Drug: sirolimus
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Immune Tolerance Network
Recruiting - verified February 2010
Condition: Coronavirus (SARS-CoV)
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified March 2009
Condition: Atopic Dermatitis
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Antithymocyte globulin; Drug: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Immune Tolerance Network
Recruiting - verified January 2010
Condition: HIV Infections
Interventions: Drug: Raltegravir (MK-0518); Drug: Raltegravir (MK-0518); Drug: Raltegravir (MK-0518)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified March 2009
Condition: Schistosomiasis [Bilharziasis]
Interventions: Drug: Placebo; Drug: Praziquantel
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2009
Condition: Malaria
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases@@@University of Bamako
Recruiting - verified March 2010
Condition: Cytomegalovirus Infections
Interventions: Drug: Placebo; Drug: Valganciclovir
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified October 2009
Condition: Macular Degeneration
Intervention: Drug: Macugen
Sponsor: Pfizer
Recruiting - verified March 2010
Conditions: Atopic Dermatitis; Eczema Herpeticum
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Conditions: MUD Transplant; AlloPBSC; Congenital Immunodeficiencies; HLA Matched Transplant; BMT
Interventions: Drug: Busulfan; Drug: Campath-1 H; Drug: Sirolimus; Procedure: BMT; Procedure: Apheresis; Procedure: Total Body Irradiation; Procedure: GCSF Injections
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified June 2009
Condition: Asthma
Intervention: Drug: beclomethasondipropionate
Sponsors: Maastricht University Medical Center; The Netherlands Asthma Foundation; Stichting Astma Bestrijding, The Netherlands
Recruiting - verified February 2010
Condition: Atopic Dermatitis
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Tuberculosis
Interventions: Biological: BCG (ID); Biological: BCG (PO); Biological: Connaught strain BCG; Drug: Placebo (ID); Drug: Placebo (PO)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Influenza
Intervention: Drug: oseltamivir (Tamiflu®)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Southern Tick-Associated Rash Illness
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Urethritis
Interventions: Drug: Azithromycin; Drug: Doxycycline
Sponsors: University of Washington; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: HIV
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified August 2009
Conditions: Tuberculosis; Pulmonary Tuberculosis
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); NIAID, Korean Center for Disease Control and Prevention, International Tuberculosis Research Center, National Masan Tuberculosis Hospital
Recruiting - verified February 2010
Conditions: Severe Malaria; Malaria; Antimalarial Drug Resistance
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified March 2010
Condition: Pneumocystis Pneumonia
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Pulmonary Hypertension
Interventions: Drug: Oral treprostinil (UT-15C) Sustained Release Tablets; Other: Placebo
Sponsor: United Therapeutics
Recruiting - verified March 2010
Condition: Pulmonary Hypertension
Interventions: Drug: bosentan; Drug: placebo
Sponsor: Actelion
Recruiting - verified March 2010
Condition: Asthma, Bronchial
Interventions: Drug: Montelukast plus prednisolone; Drug: Prednisolone
Sponsors: The Hospital for Sick Children; Merck Frosst Canada Ltd.
Recruiting - verified September 2006
Condition: BK Virus (Nephropathy)
Interventions: Drug: Cidofovir; Drug: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Norovirus
Interventions: Biological: Norwalk Virus; Drug: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Conditions: Hepatitis C; Hepatitis C, Chronic
Interventions: Procedure: Continuous maintenance immunosuppressive therapy; Procedure: Immunosuppression withdrawal; Procedure: Liver transplant
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Immune Tolerance Network
Recruiting - verified March 2010
Condition: Cytomegalovirus Infections
Interventions: Biological: CMV gB vaccine; Drug: Placebo; Biological: MF-59
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2009
Condition: Hypersensitivity, Immediate
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified September 2009
Condition: HIV Infections
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2010
Condition: Enteroviral Sepsis
Interventions: Drug: Placebo; Drug: Pleconaril (VP63843)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Immunologic Disease
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified July 2009
Conditions: HIV Infection; Kaposi's Sarcoma
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting - verified April 2009
Condition: HIV Infections
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2009
Conditions: Amebiasis; Cryptosporidiosis; Giardiasis; Parasitic Disease; Parasitic Intestinal Disease
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Conditions: Filariasis; Helminthiasis; Loiasis; Mansonelliasis; Onchocerciasis
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified March 2010
Conditions: Cystic Fibrosis; Sarcoidosis; Tuberous Sclerosis; Asthma
Intervention:
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified January 2010
Conditions: Cryptococcosis; Lymphopenia
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified December 2009
Condition: Cysticercosis
Interventions: Drug: Praziquantel; Drug: Albendazole
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2009
All Categories ... Medical Conditions » ... Allergies 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
